首页 / 院系成果 / 成果详情页

Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis-Eligible Population  期刊论文  

  • 编号:
    AB95FA54AE66D555DA16F14704E236A6
  • 作者:
    Mittelstaedt, Rachel[1,2] Kanjilal, Sanjat[3,4,5] Helekal, David Robbins, Gregory K.[1] Grad, Yonatan H.[2]
  • 语种:
    英文
  • 期刊:
    JOURNAL OF INFECTIOUS DISEASES ISSN:0022-1899 2025 年 ; 2025 JAN 15
  • 关键词:
  • 摘要:

    Among doxycycline postexposure prophylaxis (doxy-PEP)-eligible men, Staphylococcus aureus tetracycline nonsusceptibility is more prevalent than in the overall population and is associated with resistance to trimethoprim-sulfamethoxazole and clindamycin. Doxy-PEP may select for multidrug-resistant S aureus, underscoring the importance of surveillance. Among doxycycline postexposure prophylaxis (doxy-PEP)-eligible men, Staphylococcus aureus tetracycline nonsusceptibility is more prevalent than in the overall population and is associated with resistance to trimethoprim-sulfamethoxazole and clindamycin. Doxy-PEP may select for multidrug-resistant S aureus, underscoring the importance of surveillance.

  • 推荐引用方式
    GB/T 7714:
    Mittelstaedt Rachel,Kanjilal Sanjat,Helekal David, et al. Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis-Eligible Population [J].JOURNAL OF INFECTIOUS DISEASES,2025.
  • APA:
    Mittelstaedt Rachel,Kanjilal Sanjat,Helekal David,Robbins Gregory K.,&Grad Yonatan H..(2025).Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis-Eligible Population .JOURNAL OF INFECTIOUS DISEASES.
  • MLA:
    Mittelstaedt Rachel, et al. "Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis-Eligible Population" .JOURNAL OF INFECTIOUS DISEASES(2025).
  • 数据来源自科睿唯安Web of Science核心合集
  • 入库时间:
    2025/2/5 16:06:18
  • 更新时间:
    2025/2/5 16:06:18
浏览次数:8 下载次数:0
浏览次数:8
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部